KR101666348B1 - Compositions for improving skin wrinkle or enhancing skin elasticity comprising Cynanchum wilfordii and composition prepared therefrom - Google Patents
Compositions for improving skin wrinkle or enhancing skin elasticity comprising Cynanchum wilfordii and composition prepared therefrom Download PDFInfo
- Publication number
- KR101666348B1 KR101666348B1 KR1020150113930A KR20150113930A KR101666348B1 KR 101666348 B1 KR101666348 B1 KR 101666348B1 KR 1020150113930 A KR1020150113930 A KR 1020150113930A KR 20150113930 A KR20150113930 A KR 20150113930A KR 101666348 B1 KR101666348 B1 KR 101666348B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- water
- cosmetic composition
- skin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 108
- 230000037303 wrinkles Effects 0.000 title claims abstract description 69
- 230000037394 skin elasticity Effects 0.000 title claims abstract description 60
- 241000331432 Cynanchum wilfordii Species 0.000 title abstract description 5
- 230000002708 enhancing effect Effects 0.000 title abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 71
- 238000000855 fermentation Methods 0.000 claims abstract description 68
- 230000004151 fermentation Effects 0.000 claims abstract description 68
- 239000002537 cosmetic Substances 0.000 claims abstract description 59
- 239000000284 extract Substances 0.000 claims abstract description 46
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 32
- 239000011707 mineral Substances 0.000 claims abstract description 32
- 239000013535 sea water Substances 0.000 claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 18
- 244000005700 microbiome Species 0.000 claims abstract description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 235000021329 brown rice Nutrition 0.000 claims abstract description 12
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 10
- 241000018646 Pinus brutia Species 0.000 claims abstract description 10
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 10
- 235000014571 nuts Nutrition 0.000 claims abstract description 10
- 238000003809 water extraction Methods 0.000 claims abstract description 10
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 8
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 8
- 229940010454 licorice Drugs 0.000 claims abstract description 8
- 235000006533 astragalus Nutrition 0.000 claims abstract description 7
- 235000020234 walnut Nutrition 0.000 claims abstract description 6
- 244000269722 Thea sinensis Species 0.000 claims description 20
- 235000009569 green tea Nutrition 0.000 claims description 18
- 235000013305 food Nutrition 0.000 claims description 14
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 13
- 241000609240 Ambelania acida Species 0.000 claims description 10
- 239000010905 bagasse Substances 0.000 claims description 10
- 239000004927 clay Substances 0.000 claims description 10
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims description 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 241000287828 Gallus gallus Species 0.000 claims description 6
- 235000011477 liquorice Nutrition 0.000 claims description 6
- 244000018436 Coriandrum sativum Species 0.000 claims description 5
- 235000002787 Coriandrum sativum Nutrition 0.000 claims description 5
- 241000361919 Metaphire sieboldi Species 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 240000007049 Juglans regia Species 0.000 claims description 4
- 235000009496 Juglans regia Nutrition 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 claims description 3
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 claims description 3
- 240000000249 Morus alba Species 0.000 claims description 3
- 235000008708 Morus alba Nutrition 0.000 claims description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 3
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 2
- 241000195493 Cryptophyta Species 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 239000010779 crude oil Substances 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 238000004383 yellowing Methods 0.000 claims description 2
- 239000010865 sewage Substances 0.000 claims 1
- 239000005556 hormone Substances 0.000 abstract description 16
- 229940088597 hormone Drugs 0.000 abstract description 16
- 239000000047 product Substances 0.000 abstract description 14
- 239000004615 ingredient Substances 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 4
- 241000758791 Juglandaceae Species 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 5
- 244000241872 Lycium chinense Species 0.000 abstract 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract 2
- 241000209495 Acorus Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000282461 Canis lupus Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 abstract 1
- 241000336291 Cistanche deserticola Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 240000006890 Erythroxylum coca Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 241000414067 Inonotus obliquus Species 0.000 abstract 1
- 241001080798 Polygala tenuifolia Species 0.000 abstract 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract 1
- 241001618264 Rubus coreanus Species 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 244000296102 Selinum monnieri Species 0.000 abstract 1
- 235000019084 Selinum monnieri Nutrition 0.000 abstract 1
- 235000013339 cereals Nutrition 0.000 abstract 1
- 235000008957 cocaer Nutrition 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 70
- 206010040954 Skin wrinkling Diseases 0.000 description 61
- 230000000052 comparative effect Effects 0.000 description 30
- 108010035532 Collagen Proteins 0.000 description 28
- 102000008186 Collagen Human genes 0.000 description 28
- 229920001436 collagen Polymers 0.000 description 28
- 235000010755 mineral Nutrition 0.000 description 22
- 230000006872 improvement Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- 238000009472 formulation Methods 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000016942 Elastin Human genes 0.000 description 7
- 108010014258 Elastin Proteins 0.000 description 7
- 229920002549 elastin Polymers 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940011871 estrogen Drugs 0.000 description 6
- 239000000262 estrogen Substances 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000006071 cream Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- 241001474374 Blennius Species 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 229940099112 cornstarch Drugs 0.000 description 4
- 210000004177 elastic tissue Anatomy 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000005063 solubilization Methods 0.000 description 4
- 230000007928 solubilization Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000036570 collagen biosynthesis Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 108090000672 Annexin A5 Proteins 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 238000011891 EIA kit Methods 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 241001092459 Rubus Species 0.000 description 2
- 235000017848 Rubus fruticosus Nutrition 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000007012 clinical effect Effects 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- -1 white sachet Substances 0.000 description 2
- VEVRNHHLCPGNDU-MUGJNUQGSA-N (2s)-2-amino-5-[1-[(5s)-5-amino-5-carboxypentyl]-3,5-bis[(3s)-3-amino-3-carboxypropyl]pyridin-1-ium-4-yl]pentanoate Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C([O-])=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 description 1
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000383638 Allium nigrum Species 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000007016 complementary pharmacologic effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 241001233061 earthworms Species 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000012035 limiting reagent Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000001724 microfibril Anatomy 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000004354 sulfur functional group Chemical group 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
The present invention relates to a method for producing a cosmetic composition for improving skin wrinkle or skin elasticity using a natural-derived material including white mulberry, which not only has excellent skin wrinkle improving effect but also produces female hormone, and To a cosmetic composition prepared thereby.
Because the skin has many opportunities to interact with various external stimuli, it is more prone to wrinkles than other organs. Among them, facial skin is directly exposed to sunlight, dry outside air and pollutants, so that aging phenomenon such as wrinkles occurs more early than other skin.
The most characteristic change due to aging of the skin tissue is a change in the skin matrix, which causes aging of the human skin fibroblast in the dermis, resulting in a decrease in the ability to produce fibrous and matrix. The amount of the substrate is generally decreased, the thickness of the skin is thinned, and the elasticity of the skin is lowered to form the wrinkles. That is, as aging progresses, the skin becomes weaker in elasticity, disorder of blood circulation, weakening of skin barrier, and the like.
Collagen, a major component of the extracellular matrix, is a major substrate protein in the fibroblasts of the skin and is present in extracellular epilepsy. It is also an important protein that accounts for about 30% of the total weight of bioproteins, and has a solid triple helix structure.
Collagen forms most of the organic matter in the skin, tendons, bones and teeth, especially in bone and skin (dermis). In most other structures, it exists as a fibrous inclusion.
The collagen is a relatively weak immunogen, partly due to the blocking of the latent antigenic determinant by the helical structure of the collagen, which also causes the collagen to be resistant to proteolysis.
The functions of collagen present in the skin are known as mechanical rigidity of the skin, resistance of connective tissues and binding force of tissues, support of cell adhesion, induction of cell division and differentiation (when organism grows or healing) (van der Rest et al., 1990). Such collagen is reduced by aging and UV irradiation, which is known to be closely related to skin wrinkling and skin elasticity (Arthur K. Balin et al., "Aging and the skin ", 1989). In recent years, as a result of extensive research on skin aging, important functions of collagen in the skin have been revealed.
In the prior art, there have been products that incorporate collagen into cosmetics from the skin moisturizing effect of collagen, but these cosmetics apply collagen to the skin surface, and since the collagen, which is a polymer, can not be expected to be moisturized by transdermal absorption, Can not be said.
As a collagen synthesis promoting substance, retinoic acid, TGF (transforming growth factor carcinogenesis factor; Cardinale G. et al, Adv. Enzymol., 41, p. 425, 1974) -231370), betulinic acid (JP8-208424), chlorella extract (JP9-40523, JP10-36283, fibroblast proliferation promoting action) are known, but when applied to the skin, there are safety problems such as stimulation and redness The use amount is limited or the effect is insignificant, so that the skin collagen synthesis is substantially promoted and the skin function improving effect can not be expected.
Therefore, it is required to develop a composition which is safe in vivo and which is more effective than a substance promoting collagen synthesis performance.
It is an object of the present invention to provide a cosmetic composition for skin wrinkle improvement or skin elasticity enhancement using a naturally occurring substance including white sachet which not only has excellent skin wrinkle improving effect but also produces female hormone Method.
Another object of the present invention is to provide a cosmetic composition prepared by the above-mentioned method.
In order to accomplish the above object, the present invention provides a cosmetic composition for improving skin wrinkles or skin elasticity using a natural derived material comprising white sachet (A) Useful microorganisms such as liquorice, acacia, brown rice, yeast, zucchini, EM solution; Mixing the mineral water with mineral water, adding the deep sea water and yellow clay water to the first fermentation;
(B) injecting air under the same temperature as that of the primary fermentation to perform secondary fermentation;
(C) Mixed with deep seawater, concentrated water of mineral water and deep sea water, pine nut, hwanggi, jaejong yong, paulchiae, mugwort, raw paper, Killer, Seokchangpo, Seokgiwang, Baekbyeong, Hwangjeong, Broiler, Red ginseng, Extracting the hot water;
(D) separating the fermented product fermented in step (B) into a fermentation broth and a residue;
(E) hot water extraction of the residue separated in step (D); And
(F) mixing the fermentation broth separated in step (D), the extract extracted in step (E), and the extract extracted in step (C).
50 to 600 parts by weight of the group consisting of bokbunja, earthworm, casualty, gugija, omija, acidophilus, and ogap is 100 parts by weight in the step (A) 5 to 10 parts by weight of brown rice; 5 to 10 parts by weight of yeast; 100 to 300 parts by weight of crude oil; 100 to 300 parts by weight of useful microorganisms; 20 to 100 parts by weight of mineral concentrated water; 1500 to 2000 parts by weight of deep ocean water; And 1,500 to 2,000 parts by weight of yellow clay.
In the step (A), the primary fermentation may be performed at 20 to 50 ° C for 12 to 20 days.
In the step (B), the secondary fermentation may be performed for 12 to 20 days.
100 to 300 parts by weight of sulfur based on 100 parts by weight of bagasse in step (C); 100 to 3500 parts by weight of a group consisting of green tea, green tea, green tea, green tea, kelp, kochujang, seokjanghwang, white bongryeong, hwangjeong, broiler, red ginseng, pine nut and walnut; 100-400 parts by weight of a group consisting of licorice and coriander; 20 to 50 parts by weight of mineral concentrated water; And deep sea water at 1000 to 20,000 parts by weight.
In the step (C), the hot-water extract may be a mixture obtained by extracting the mixture at 70 to 90 ° C. for 100 to 130 hours.
In the step (E), the hot-water extract may be a mixture of the residue and water at a weight ratio of 1: 1 to 3 and extracted at 70 to 90 ° C for 10 to 30 hours.
In step (F), the fermentation broth separated in step (D), the extract extracted in step (E), and the extract extracted in step (C) are mixed at a weight ratio of 1: 0.2-0.8: 0.5-3.0 .
According to another aspect of the present invention, there is provided a cosmetic composition for improving skin wrinkles or skin elasticity.
The composition may be in the form of a solution, an external ointment, a cream, a foam, a nutritional lotion, a softening longevity pack, a softener, a milky lotion, a makeup base, an essence, a soap, a liquid detergent, , A gel, a lotion, a powder, a soap, a surfactant-containing cleansing, an oil, a powdered foundation, an emulsion foundation, a wax foundation, a patch and a spray.
According to another aspect of the present invention, there is provided a method for manufacturing a skin composition for improving skin wrinkles or skin elasticity, comprising the steps of: (A) preparing a composition for skin wrinkles or skin elasticity, Useful microorganisms such as Nuruk, Chojung and EM solution; Mixing the mineral water with mineral water, adding the deep sea water and yellow clay water to the first fermentation;
(B) injecting air under the same temperature as that of the primary fermentation to perform secondary fermentation;
(C) Mixed with deep seawater, concentrated water of mineral water and deep sea water, pine nut, hwanggi, jaejong yong, paulchiae, mugwort, raw paper, Killer, Seokchangpo, Seokgiwang, Baekbyeong, Hwangjeong, Broiler, Red ginseng, Extracting the hot water;
(D) separating the fermented product fermented in step (B) into a fermentation broth and a residue;
(E) hot water extraction of the residue separated in step (D); And
(F) mixing the fermentation broth separated in step (D), the extract extracted in step (E), and the extract extracted in step (C).
The cosmetic composition for improving skin wrinkles or skin elasticity according to the present invention has an excellent collagen synthesis promoting activity, and therefore can have an effect of improving skin wrinkles or enhancing skin elasticity.
In addition, the cosmetic composition of the present invention can induce postmenopausal menstruation again because it produces female hormone, and can improve the calm feeling after menopause and maintain good mood.
In addition, the composition of the present invention can be applied not only to cosmetics to be applied but also to cosmetics to be eaten, but also to foods.
The present invention relates to a method for producing a cosmetic composition for improving skin wrinkle or skin elasticity using a natural-derived material including white seaweed, which not only has excellent skin wrinkle improving effect but also produces female hormone, And to a cosmetic composition prepared thereby.
In the present invention, "skin wrinkle" refers to a scarring caused by skin damage, which may be caused by a cause of a gene, a decrease in collagen and elastin present in the skin dermis, and an external environment.
In the present invention, "improvement of skin wrinkles" refers to inhibiting or inhibiting the generation of wrinkles on the skin, or alleviating already formed wrinkles.
In the present invention, "skin elasticity" is expressed by elastic fibers composed of elastin existing in the dermal layer. Such elastic fibers have a very low elastic modulus such as rubber and are easily deformed by a small force, When the force is removed, it easily returns to the original shape. In addition, the elastic fibers have a form in which microfibrils are embedded in an amorphous matrix called elastin, and elastin is a protein that is found only in elastic fibers such as desmosine and isodesmosine derived from lysine, It is a protein composed of one amino acid. These desmosins and isodesmesynes form cross-links in long peptide chains, which makes elastin behave like a rubber.
In the present invention, "skin elasticity enhancement" refers to elasticity fibers composed of elastin together with collagen fibers called collagen, wherein skin elasticity is maintained in a state where elastin and collagen are sufficiently present.
Hereinafter, the present invention will be described in detail.
A method for producing a cosmetic composition for improving skin wrinkles or skin elasticity using a naturally-occurring material comprising white sachet of the present invention comprises the steps of: (A) (B) injecting air under the same temperature as that of the primary fermentation to perform secondary fermentation; (C) hot water extraction by mixing white algae and other natural substances; (D) separating the fermented product fermented in step (B) into a fermentation broth and a residue; (E) hot water extraction of the residue separated in step (D); And (F) mixing the fermentation broth separated in step (D), the extract extracted in step (E), and the extract extracted in step (C).
First, in step (A) above, At least one member selected from the group consisting of bokbunja, earthworm, casualty, gojira, omija, mackerel and ogapi; Brown rice; yeast; Cho Chung; Useful microorganisms; After mixing the mineral concentrated water, deep ocean water; And yellow clinging factor are added to the first fermentation.
The above-mentioned Bacillus subtilis is an Asclepiadaceae large gourd (Cynanchum wilfordii Hemsley), and is a root plant and has the efficacy of nourishment, blood, blood (补 精) and leiomyoma (leukemia) It is used for white hair (early white hair), nervous breakdown, chronic airflow (chronic wind).
When at least one selected from the group consisting of brambles, earthworms, casualties, gougie, omija, liquorice, and ogapi is fermented together with white seaweed, it can improve skin wrinkles, improve skin elasticity, It uses bokbunja, tosajeon, casualties, gogija, omija, mackerel and ogapi.
At least one selected from the group consisting of brambles, dead animals, casualties, gypsum, omija, liquorice, and acacia is used in an amount of 50 to 600 parts by weight based on 100 parts by weight of white mud. 1: 1: 1: 1: 1. If the content of at least one selected from the group consisting of bokbunja, skin cancer, casualties, phlegm, omija, acidophilus and ogapi is lower than the lower limit, wrinkles may not be improved and skin elasticity may not be enhanced. Can occur.
The brown rice is preferably brown rice, which is mixed with the bagasse to improve skin wrinkles and improve skin elasticity during fermentation. The brown rice is mixed with 5 to 10 parts by weight, preferably 6 to 8 parts by weight, based on 100 parts by weight of white soda. When the content of the brown rice is less than the lower limit, excellent wrinkles are not improved and skin elasticity may not be enhanced, and when the content is above the upper limit value, resources can be wasted because it can not induce more excellent effects.
The yeast is a traditional fermentation agent of Korea, and the commonly used yeast is used to ferment other naturally occurring substances by mixing with useful microorganisms to improve skin wrinkles and skin elasticity, as well as to produce female hormones, Help. If none of the yeast and useful microorganisms are used, the skin wrinkles and skin elasticity may not be improved but may be lowered, and there is no effect on female hormones.
Nuruk is mixed in an amount of 5 to 10 parts by weight, preferably 6 to 8 parts by weight, based on 100 parts by weight of white bagasse. If the content of the yeast is below the lower limit, the fermentation may not be performed. If the content of the yeast exceeds the upper limit, the yeast is used more than necessary and resources are wasted.
The above-mentioned starch is used for fermentation, and specific examples thereof include cornstarch, bellflower, cornstarch and black garlic, preferably cornstarch.
The content of tonic acid is 100 to 300 parts by weight, preferably 150 to 200 parts by weight, based on 100 parts by weight of white seaweed. Fermentation may not be carried out when the content of oranges is less than the above lower limit, and in the case of exceeding the upper limit, waste more than necessary is used and resources are wasted.
The beneficial microorganism (EM) is mixed with yeast to ferment naturally occurring substances, thereby improving skin wrinkles and improving skin elasticity.
The content of the useful microorganism is 100 to 300 parts by weight, preferably 100 to 150 parts by weight based on 100 parts by weight of the bagasse. When the content of the useful microorganism is less than the lower limit, skin wrinkles and skin elasticity may not be enhanced. If the content of the microorganisms is above the upper limit value, unnecessary useful microorganisms are used and resources are wasted.
The mineral-enriched water is obtained by concentrating deep-sea water having a hardness of 300 mg / L to a hardness of 230,000 to 290,000 mg / L. The hardness is an index indicating the content of calcium carbonate in the water, which corresponds to the sum of the contents of calcium ions and magnesium ions in water. The higher the hardness, the larger the amount of minerals contained. When the hardness of the mineral-concentrated water is less than the lower limit, minerals such as calcium and magnesium can not be supplied to the skin. If the hardness of the mineral-concentrated water is above the upper limit, skin troubles may occur.
The content of the mineral-enriched water is 20 to 100 parts by weight, preferably 30 to 50 parts by weight, based on 100 parts by weight of the bagasse. When the content of the mineral-concentrated water is less than the lower limit value, excellent skin wrinkles and skin elasticity can not be expected. If the content is above the upper limit, skin trouble may occur.
In the present invention, it is necessary to first mix a mineral-concentrated water having a high hardness and natural-derived materials to coat or impregnate a large amount of concentrated minerals on the surface of natural-derived materials, and then ferment the marine deep- And minerals can improve their efficacy by fermentation. In this case, when the deep sea water and the yellow clay are added together with the mineral concentrated water later, it is not expected to improve the skin wrinkles and skin elasticity.
The content of the deep seawater is 1500 to 2000 parts by weight, preferably 1600 to 1700 parts by weight, based on 100 parts by weight of white seaweed. If the content of the deep sea water is out of the above range, it may interfere with fermentation.
The above-mentioned yellow clay is a supernatant after standing for 20 to 25 hours in a mixture of yellow soil and water, and contains various minerals such as potassium, sodium and iron, which are contained in mineral concentrated water and deep seawater, .
The content of the yellowing agent is 1500 to 2000 parts by weight, preferably 1600 to 1700 parts by weight, based on 100 parts by weight of the bagasse. When the content of the yellow clay is less than the lower limit, various minerals can not be supplied to the skin. If the content is above the upper limit, the yellow clay is used more than necessary and resources are wasted.
The mixture mixed in the step (A) is firstly fermented at 20 to 50 ° C, preferably 25 to 30 ° C for 12 to 20 days, preferably 13 to 14 days. During the first fermentation, the fermentation vessel is turned over once a day to allow the fermentation to be performed well. When the fermentation temperature and time are out of the above range, fermentation may not be performed well, and in particular, if the fermentation temperature is higher than the upper limit value, skin trouble may be caused.
Next, in the step (B), air is injected under the same temperature as that of the primary fermentation for secondary fermentation.
Air is injected for 12 to 20 days, preferably 13 to 14 days at the same temperature as the primary fermentation, thereby performing secondary fermentation while air bubbles are formed in the fermentation product.
When fermentation is carried out without air injection, secondary fermentation is not smoothly performed and, in some cases, toxicity may be induced.
In the present invention, step (C) is performed separately from steps (A) and (B).
On the other hand, in the step (C), Hwang, Ki - Young At least one selected from the group consisting of green tea, green tea, green tea, pine nut and walnut; At least one selected from the group consisting of licorice and coriander; Mineral concentrated water; And deep sea water are mixed and subjected to hot water extraction.
It is used together with the fermented product prepared in the step (B) to greatly enhance skin wrinkles and skin elasticity, and to produce female hormones, Hwanggi is used.
The content of the sulfur group is 100 to 300 parts by weight, preferably 120 to 150 parts by weight based on 100 parts by weight of the white soda. When the content of the hwanggi is less than the lower limit, the skin wrinkles and the skin elasticity are not improved and the female hormone is not produced. If the content is above the upper limit value, the skin wrinkles may occur and the elasticity of the skin may be lowered.
In addition, in order to further improve the skin wrinkles and skin elasticity, it is mixed with the fermented product prepared in step (B) to further improve skin wrinkles and skin elasticity. Pine nut, and walnut, preferably at least one of the above 14 species.
The content of at least one selected from the group consisting of green tea, green tea, green tea, green tea, green tea, green tea, korean tea, kochujang, Wealth. If the content is below the lower limit, skin wrinkles and skin elasticity may not be enhanced. If the content is above the upper limit, skin troubles and toxicity may be caused.
Also, in order to produce female hormone by mixing with the fermented product prepared in step (B), one or more selected from the group consisting of licorice and coriander, preferably two of them, are used together.
The content of at least one selected from the group consisting of licorice and coriander is 100 to 400 parts by weight with respect to 100 parts by weight of the bagasse. Licorice, and goji, the female hormone can not be produced. If the upper limit is exceeded, the female hormone may be weakly produced.
The content of the mineral-concentrated water is 20 to 50 parts by weight, preferably 25 to 30 parts by weight, based on 100 parts by weight of the bagasse. When the content of mineral-concentrated water is less than the lower limit value, skin wrinkles and skin elasticity are not enhanced, and when the content is above the upper limit value, no further effect is promoted.
The deep seawater is used for hot water extraction and is preferably used in an amount of 1000 to 20,000 parts by weight per 100 parts by weight of the bagasse.
The hot-water extract in step (C) is obtained by extracting the mixture at 70 to 90 ° C. for 100 to 130 hours, preferably 120 to 130 hours. If the extraction temperature and time are out of the above range, the active substances may not be extracted.
Next, in step (D), the secondary fermentation product fermented in the step (B) is filtered and separated into a fermentation broth and a residue.
The secondary fermented product is separated by filtration into a fermentation broth and a residue.
Next, in the step (E), the residue separated in the step (D) is extracted with hot water.
The residue separated in the step (D) and water are mixed at a weight ratio of 1: 1 to 3 and extracted with hot water at 70 to 90 ° C for 10 to 30 hours, preferably 15 to 20 hours to obtain an extract.
When the extraction temperature and the extraction time are out of the above range, the effective substance contained in the residue can not be extracted.
Next, in step (F), the fermentation broth separated in step (D), the residue extract extracted in step (E), and the extract extracted in step (C) are mixed.
The fermentation broth separated in step (D), the residue extract extracted in step (E), and the extract extracted in step (C) are mixed at a weight ratio of 1: 0.2-0.8: 0.5-3.0, 0.7: 1.0-1.5. When the content of the residue extract extracted at step (E) and the extract extracted at step (C) are lower than the lower limit value based on the fermentation broth separated in step (D), the skin wrinkles and skin elasticity are not improved and female hormone If it exceeds the upper limit value, it is toxic and skin trouble may occur.
If any of the fermentation broth separated in step (D), the residue extract extracted in step (E), and the extract extracted in step (C) is omitted, the skin wrinkles and skin elasticity can not be enhanced and female hormones can not be produced.
The naturally-occurring materials used in the present invention should be prepared according to the manufacturing method of the present invention, so that complementary pharmacological effects are exerted to improve skin wrinkles, promote skin elasticity, and produce female hormones.
The cosmetic composition for skin wrinkle improvement or skin elasticity enhancement of the present invention may be blended with cosmetic composition for skin wrinkle improvement or skin elasticity enhancement prepared according to the above production method, Examples of such a compounding component include a preservative, a humectant, an emollient, a surfactant, an organic and inorganic pigment, an organic powder, an ultraviolet absorber, an antiseptic, a bactericide, an antioxidant, a pH adjuster, an alcohol, a pigment, Limiting agents, and purified water.
The cosmetic composition for improving skin wrinkles or improving skin elasticity may be prepared in the form of an emulsified formulation and a solubilized formulation commonly used in the art, and examples thereof include a solution, an external ointment, a cream, a foam, a nutritional lotion, Sunscreen creams, sun oil, suspensions, emulsions, pastes, gels, lotions, powders, soaps, surfactant-containing cleansing, oils, powder foundations , Emulsion foundation, wax foundation, patch, spray, and the like. In particular, the cosmetic composition for improving skin wrinkles or skin elasticity according to the present invention is preferable for cream or for eating cosmetics.
The present invention also provides a method for producing a food composition for improving skin wrinkles or improving skin elasticity.
Foods containing the food composition of the present invention include, for example, various foods, beverages, gums, tea, vitamin complex, and the like, but are not limited thereto.
The food composition for improving skin wrinkles or skin elasticity of the present invention includes forms such as tablets, capsules, pills, and liquids.
The beverage composition for improving skin wrinkles or improving skin elasticity of the present invention is not particularly limited to other components except for containing the food composition as an essential ingredient at the indicated ratio, and may be added with various flavors or natural carbohydrates As a component. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And polysaccharides, for example, conventional sugars such as dextrin, cyclodextrin and the like, and sugar alcohols such as xylitol, sorbitol and erythritol. Natural flavors (tau martin, stevia extracts (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavors (saccharin, aspartame, etc.) can be advantageously used as flavors other than those described above The ratio of the natural carbohydrate is generally about 1 to 20 g, preferably about 5 to 12 g per 100 ml of the food composition of the present invention.
In addition to the above, the food composition of the present invention can be used as a flavoring agent such as a variety of nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, coloring agents and thickening agents (cheese, chocolate etc.), pectic acid and its salts, Salts thereof, organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like.
In addition, the food composition of the present invention may contain natural fruit juice and pulp for the production of fruit juice drinks and vegetable drinks. These components may be used independently or in combination. The proportion of such additives is not so critical, but is generally selected in the range of 0 to about 20 parts by weight per 100 parts by weight of the food composition of the present invention.
It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit or scope of the present invention. Such variations and modifications are intended to be within the scope of the appended claims.
Preparation Example 1. Preparation of the compound of step (A)
83 parts by weight of ginseng, 83 parts by weight of ginseng, 83 parts by weight of casualties, 83 parts by weight of casualties, 83 parts by weight of gumigae, 83 parts by weight of omija, 83 parts by weight of acid, and 83 parts by weight of ogapi were mixed with 6.6 parts by weight of rice brown rice, And 166 parts by weight of cornstarch, and then 33 parts by weight of mineral concentrated water and 100 parts by weight of useful microorganisms were added and mixed. Then, 1,600 parts by weight of deep sea water and 1,600 parts by weight of yellow clay were added.
Preparation Example 2. Preparation of the compound of step (C)
100 weight parts of white mud, 125 weight parts of sulfuric acid, 125 weight parts of green tea, 125 weight parts of cornstalks, 125 weight parts of curds, 125 weight parts of raw paper, 125 weight parts of kills, 125 weight parts of Seokchangpo, 125 parts by weight of Hwangjeol, 125 parts by weight of Korean red ginseng, 125 parts by weight of red ginseng, 125 parts by weight of chaga mushroom, 125 parts by weight of pine nuts and 125 parts by weight of walnuts were mixed with 100 parts by weight of licorice and 100 parts by weight of ginger, And 10000 parts by weight of deep sea water were added and mixed, followed by extraction at 80 DEG C for 120 hours to obtain a hot-water extract.
Example 1.
The compound of Preparation Example 1 was subjected to primary fermentation (inversion of the fermentation vessel once a day) at 30 ° C. for 14 days, then air was injected at the same temperature for 14 days to perform secondary fermentation Next, the secondary fermentation product was filtered and separated into a fermentation broth and a residue.
The residue and water were mixed at a weight ratio of 1: 2 and extracted at 80 DEG C for 20 hours to obtain a residue extract.
The filtered fermentation broth, the residue extract and the hot water extract of Preparation Example 2 were mixed at a weight ratio of 1: 0.6: 1.5 to prepare a cosmetic composition.
Comparative Example 1. Fermentation Omission
The compound of Preparation Example 1 and the hot-water extract of Preparation Example 2 were mixed at a weight ratio of 1: 2.1 to prepare a cosmetic composition.
Comparative Example 2. Omission of residue extract
The same procedure as in Example 1 was carried out except that the filtered fermentation broth without using the residue extract and the hot water extract of Preparation Example 2 were mixed at a weight ratio of 1: 2.1 to prepare a cosmetic composition.
Comparative Example 3. Manufacturing example 2 of Heat number Omit extract
The same procedure as in Example 1 was conducted except that the filtered fermentation broth and the residue extract were mixed at a weight ratio of 1: 2.1 to prepare a cosmetic composition.
< Test Example >
Test Example 1. Cytotoxicity test
Cytotoxicity was measured according to the concentration of the cosmetic composition prepared in Examples and Comparative Examples.
Cytotoxicity was measured by the method of Rochem et al. In order to carry out the test in the safety concentration range of the sample. Cells (2 × 10 5 cells / well) (RAW 264.7) were seeded in 24-well plates and cultured for 24 hours. After that, the medium was removed and 1 mL of the medium containing 3% of the serum in which the extract was dissolved was dispensed and cultivation was carried out for 24 hours. After 24 hours, 0.25 mL of XTT-PMS solution (1 mg XTT and 10 g PMS / mL of MEM without phenol red) was added to each well and incubated for another 2 hours. The degree of cytotoxicity was determined by measuring the absorbance of formazan at 450 nm using a microplate reader. The medium was MEM supplemented with 10% (v / v) fetal bovine serum (FBS), 0.5% (v / v) 50 g / mL streptomycin, 50 IU / mL penicillin, 0.125 g / mL fungizone, 3.024 g sodium bicarbonate And incubated at 37 ℃, 5% CO 2, 95% humidified air.
As shown in Table 1, it was confirmed that the cosmetic composition prepared according to Example 1 of the present invention showed no toxicity in the interval of 10 to 100 占 퐂 / ml.
On the other hand, in Comparative Example 1, toxicity was observed in the entire section of 10 to 100 占 퐂 / ml, while in Comparative Examples 2 and 3, toxicity was observed in 25 占 퐂 / ml.
Test Example 2. Collagen Sum performance
The effect of wrinkle improvement or skin elasticity improvement can usually be measured as collagen biosynthesis performance, collagenase degradation inhibition ability and human clinical effect. The cosmetic composition prepared in Examples and Comparative Examples was added to a culture solution of human-derived fibroblasts to examine the promoting effect of collagen synthesis at the cellular level. The biosynthetic collagen was quantitated using a PICP EIA kit (Procollagen Type I CPeptide Enzyme Immunoassay KIT).
Human normal fibroblasts were cultured in DMEM medium at 37 ° C for 24 hours in a 5% CO 2 incubator. The cosmetic composition and vitamin C (Vitamin C) were added to the human fibroblast culture medium and cultured for 1 day with the control (untreated). After 1 day, the amount of collagen biosynthesis was determined by the PICP EIA kit at 450 nm using a spectrophotometer. Calculation of collagen biosynthesis performance is shown in Table 2, measured by the relative increase in relative performance compared to the control (untreated).
As shown in Table 2 above, it was confirmed that the cosmetic composition prepared according to Example 1 of the present invention was superior in collagen synthesis to vitamin C and Comparative Examples 1 to 3. Particularly, it was confirmed that collagen synthesis ability was the most excellent at 50 占 퐂 / ml of Example 1.
This means that the cosmetic composition of Example 1 exhibits excellent collagen combining performance against human-derived fibroblasts.
Test Example 3. Effect of wrinkle improvement
The wrinkle-reducing effect was measured using the experimental group treated with the cosmetic composition prepared according to Examples and Comparative Examples and the control group not treated. Wrinkle-improving effect The animal test was performed using a hairless mouse that was 6 weeks old. As a sample, the cosmetic composition was applied to 1,3-butylene glycol at 50 μg / ml. Hairless mice were irradiated with MED (minimal crythema dosis) using a solar simulator for 1 week to 3 days for 10 weeks to form wrinkles. Then, 1,3-butylene glycol (Butylene glycol) and 50 ㎍ / ㎖ of cosmetic composition were treated with 0.1 ml / cm 2 twice a day for 6 weeks.
The degree of wrinkle improvement was determined by naked eyes through naked eyes and photographs, and then the sample treatment group and the control group were compared according to the following criteria compared with before treatment. The population of each group is 10.
As shown in Table 3 above, it was confirmed that the cosmetic composition prepared according to Example 1 of the present invention exhibited excellent wrinkle-reducing effect as compared with the control group and Comparative Examples 1 to 3.
Test Example 4. Wrinkle improvement and skin elasticity Clinical effect
A sample containing the present invention (Example 1, Comparative Example 1-3) was applied to 1,3-butylene glycol at a concentration of 50 占 퐂 / ml to 100 subjects (25 subjects per sample) After that, it was applied twice a day in the morning and in the evening for 3 months. The degree of wrinkle improvement and skin elasticity after use was judged according to the following criteria.
As shown in Table 4, the cosmetic composition prepared according to Example 1 of the present invention exhibited excellent wrinkle-improving effect and confirmed that skin elasticity was improved.
On the other hand, Comparative Example 1 showed no improvement in wrinkle and skin elasticity, and Comparative Examples 2 and 3 also showed lower wrinkle and skin elasticity.
Test Example 5. Estrogen content measurement
Six-week old female Sprague Dawley (200 g) experimental animals were added with the food composition prepared in Examples and Comparative Examples to a concentration of 50 μg / ml in the feed, and the feeds were taken for 28 days, respectively. Control groups were fed diets without added food composition.
The ovaries were isolated from each group, and the animals were sacrificed for 16 hours before the autopsy. The anesthetized animals were anesthetized and the abdominal cavity was opened. Blood was collected from the abdominal vein and centrifuged at 2500 rpm for 15 minutes After isolating the serum, the following results were obtained by RIA method.
(pg / ml)
As shown in Table 5, it was confirmed that the composition prepared according to Example 1 of the present invention produced a large amount of estrogen.
On the other hand, in Comparative Examples 1 to 3, estrogen was not produced because the estrogen content of the control group was similar.
Since the composition of Example 1 produces a large amount of estrogen, female hormone can be supplied.
<Formulation example>
Hereinafter, formulation examples of the composition containing the extract of the present invention will be described, but the present invention is not intended to be limited thereto but is specifically described.
Formulation Example 1. Preparation of cosmetic product of emulsified formulation
Cosmetics of emulsified form such as nutrient lotion, cream, essence, and cosmetics of solubilized form such as softened longevity were prepared.
Emulsifier type cosmetics were prepared in the compositions shown in Table 6 below. The production method is as follows.
1) A mixture of raw materials 1 to 9 was heated to 65 to 70 占 폚.
2) The starting material of 10 was added to the mixture of step 1).
3) The mixture of raw materials 11 to 13 was completely dissolved by heating to 65 to 70 占 폚.
4) While the above step 3) was carried out, the mixture of step 2) was gradually added and emulsified at 8,000 rpm for 2 to 3 minutes.
5) The raw material of 14 was dissolved in a small amount of water and then added to the mixture of step 4) and further emulsified for 2 minutes.
6) The raw materials of 15 to 17 were each weighed, and then put into the mixture of step 5) and further emulsified for 30 seconds.
7) The mixture of step 6) was degassed after emulsification and cooled to 25-35 占 폚 to prepare an emulsifier-type cosmetic.
Monolauric acid ester
Formulation example 2. Solubilization Manufacture of Cosmetics for Formulation
Cosmetic products of the solubilized formulations were prepared with the compositions shown in Table 7 below. The production method is as follows.
1) 2 to 6 raw materials were put into 1 raw material (purified water) and dissolved using a mixer.
2) Raw materials 8 to 11 were completely dissolved in 7 raw materials (alcohol).
3) The mixture of step 2) was slowly solubilized by adding it to the mixture of step 1).
Hydro genide ester
Formulation Example 3. Preparation of Eating Cosmetics
Composition of Example 1 19 kg
Betaclaran 5 kg
Collagen 0.6 kg
Fructose 4 kg
Alpha tocopherol 0.3 kg
Pectin 0.5 kg
Citric acid 0.3 kg
Purified water 50 L
Number of conversions 100 L
Formulation Example 4. Preparation of functional beverage
The composition of Example 1 1,000 mg
Citric acid 1,000 mg
100 g of oligosaccharide
Plum concentrate 2 g
Taurine 1 g
Purified water was added to the flask to obtain a total of 900 mL
The above components were mixed according to a conventional health drink manufacturing method, and the mixture was stirred and heated at 85 DEG C for about 1 hour. The solution thus prepared was filtered and sterilized in a sterilized 2 L container, It is used in the production of the functional beverage composition of the invention.
Although the composition ratio is a mixture of the components suitable for the preferred beverage as a preferred embodiment, the blending ratio may be arbitrarily varied according to the regional and national preferences such as the demand level, the demanding country, and the intended use.
Claims (10)
(B) injecting air under the same temperature as that of the primary fermentation to perform secondary fermentation;
(C) Mixed with deep seawater, concentrated water of mineral water and deep sea water, pine nut, hwanggi, jaejong yong, paradigm, mulberry, raw paper, killing, Seokchangpo, Seokgiwang, Baekbyeong, Hwangjeong, broiler, red ginseng, Extracting the hot water;
(D) separating the fermented product fermented in step (B) into a fermentation broth and a residue;
(E) hot water extraction of the residue separated in step (D); And
(F) mixing the fermentation broth separated in the step (D), the extract extracted in the step (E) and the extract extracted in the step (C). A method for producing a cosmetic composition for improving skin wrinkles or skin elasticity using a derived material.
(B) injecting air under the same temperature as that of the primary fermentation to perform secondary fermentation;
(C) Mixed with deep seawater, concentrated water of mineral water and deep sea water, pine nut, hwanggi, jaejong yong, paradigm, mulberry, raw paper, killing, Seokchangpo, Seokgiwang, Baekbyeong, Hwangjeong, broiler, red ginseng, Extracting the hot water;
(D) separating the fermented product fermented in step (B) into a fermentation broth and a residue;
(E) hot water extraction of the residue separated in step (D); And
(F) mixing the fermentation broth separated in the step (D), the extract extracted in the step (E) and the extract extracted in the step (C). A method for producing a food composition for improving skin wrinkles or skin elasticity using a derived material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150113930A KR101666348B1 (en) | 2015-08-12 | 2015-08-12 | Compositions for improving skin wrinkle or enhancing skin elasticity comprising Cynanchum wilfordii and composition prepared therefrom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150113930A KR101666348B1 (en) | 2015-08-12 | 2015-08-12 | Compositions for improving skin wrinkle or enhancing skin elasticity comprising Cynanchum wilfordii and composition prepared therefrom |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101666348B1 true KR101666348B1 (en) | 2016-10-17 |
Family
ID=57250151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150113930A KR101666348B1 (en) | 2015-08-12 | 2015-08-12 | Compositions for improving skin wrinkle or enhancing skin elasticity comprising Cynanchum wilfordii and composition prepared therefrom |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101666348B1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180044044A (en) * | 2016-10-21 | 2018-05-02 | 김수경 | Soap Containing Fermented Medicinal Herbs Include Ginseng, and Method for Manufacturing the Same |
KR101885648B1 (en) | 2018-01-31 | 2018-08-06 | 신보현 | Composition comprising an extract of Cynanchi wilfordii, Polygonatum falcatum A. Gray, Petasites japonicas and Laminaria japonica for preventing or treating of stomach cancer |
KR101949713B1 (en) * | 2017-11-20 | 2019-02-19 | 김수경 | Method for Manufacturing Oriental Medicine Soap Improving Atopic Dermatitis |
CN109846762A (en) * | 2018-09-17 | 2019-06-07 | 上海珈凯生物科技有限公司 | A kind of composition with white-skinned face function and preparation method thereof, application |
KR102011109B1 (en) | 2019-03-25 | 2019-08-16 | 리봄화장품 주식회사 | Cosmetic composition with sodium polyitaconate and method for producing the same |
CN115040465A (en) * | 2022-07-06 | 2022-09-13 | 浙江爱尚日用品有限公司 | Whitening toothpaste capable of effectively removing dental plaque and tartar |
KR102468885B1 (en) * | 2022-03-10 | 2022-11-18 | 농업회사법인 고산 주식회사 | Method for manufacturing earthworm farm malodor remover and earthworm farm malodor remover produced thereby |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100564108B1 (en) * | 2004-01-12 | 2006-03-24 | 주식회사 생그린 | Cosmetic composition comprising plant extract having anti-aging effect |
KR20090063456A (en) | 2007-12-14 | 2009-06-18 | (주)내츄럴엔도텍 | Compositions for improving skin conditions |
KR20090081810A (en) | 2008-01-25 | 2009-07-29 | 코스맥스 주식회사 | Cosmetic composition containing herb extracts |
KR20100028601A (en) | 2010-01-25 | 2010-03-12 | (주)내츄럴엔도텍 | Compositions for improving skin conditions comprising extract of cynanchum wilfordii |
KR20100101258A (en) * | 2009-03-09 | 2010-09-17 | 주식회사 엘씨에스바이오텍 | Methods for fermentation of natural plants or herbal medicines and fermented products using the same methods |
KR20130047778A (en) * | 2011-10-25 | 2013-05-09 | (주)아모레퍼시픽 | Fermentation method using medicinal flower and skin external composition containing fermented extract by the method |
KR20150063336A (en) * | 2015-05-18 | 2015-06-09 | 주식회사 파인바이오 | Cosmetic manufacturing method using natural originated material and cosmetic thereof |
-
2015
- 2015-08-12 KR KR1020150113930A patent/KR101666348B1/en active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100564108B1 (en) * | 2004-01-12 | 2006-03-24 | 주식회사 생그린 | Cosmetic composition comprising plant extract having anti-aging effect |
KR20090063456A (en) | 2007-12-14 | 2009-06-18 | (주)내츄럴엔도텍 | Compositions for improving skin conditions |
KR20090081810A (en) | 2008-01-25 | 2009-07-29 | 코스맥스 주식회사 | Cosmetic composition containing herb extracts |
KR20100101258A (en) * | 2009-03-09 | 2010-09-17 | 주식회사 엘씨에스바이오텍 | Methods for fermentation of natural plants or herbal medicines and fermented products using the same methods |
KR20100028601A (en) | 2010-01-25 | 2010-03-12 | (주)내츄럴엔도텍 | Compositions for improving skin conditions comprising extract of cynanchum wilfordii |
KR20130047778A (en) * | 2011-10-25 | 2013-05-09 | (주)아모레퍼시픽 | Fermentation method using medicinal flower and skin external composition containing fermented extract by the method |
KR20150063336A (en) * | 2015-05-18 | 2015-06-09 | 주식회사 파인바이오 | Cosmetic manufacturing method using natural originated material and cosmetic thereof |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180044044A (en) * | 2016-10-21 | 2018-05-02 | 김수경 | Soap Containing Fermented Medicinal Herbs Include Ginseng, and Method for Manufacturing the Same |
KR101893012B1 (en) * | 2016-10-21 | 2018-08-29 | 김수경 | Method for Manufacturing Soap Containing Fermented Medicinal Herbs Include Ginseng |
KR101949713B1 (en) * | 2017-11-20 | 2019-02-19 | 김수경 | Method for Manufacturing Oriental Medicine Soap Improving Atopic Dermatitis |
KR101885648B1 (en) | 2018-01-31 | 2018-08-06 | 신보현 | Composition comprising an extract of Cynanchi wilfordii, Polygonatum falcatum A. Gray, Petasites japonicas and Laminaria japonica for preventing or treating of stomach cancer |
CN109846762A (en) * | 2018-09-17 | 2019-06-07 | 上海珈凯生物科技有限公司 | A kind of composition with white-skinned face function and preparation method thereof, application |
KR102011109B1 (en) | 2019-03-25 | 2019-08-16 | 리봄화장품 주식회사 | Cosmetic composition with sodium polyitaconate and method for producing the same |
KR102468885B1 (en) * | 2022-03-10 | 2022-11-18 | 농업회사법인 고산 주식회사 | Method for manufacturing earthworm farm malodor remover and earthworm farm malodor remover produced thereby |
CN115040465A (en) * | 2022-07-06 | 2022-09-13 | 浙江爱尚日用品有限公司 | Whitening toothpaste capable of effectively removing dental plaque and tartar |
CN115040465B (en) * | 2022-07-06 | 2023-01-24 | 浙江爱尚日用品有限公司 | Whitening toothpaste capable of effectively removing dental plaque and tartar |
US11771644B1 (en) | 2022-07-06 | 2023-10-03 | Zhejiang Airsun Commodity Co., Ltd. | Whitening toothpaste capable of effectively removing dental plaque and tartar |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101666348B1 (en) | Compositions for improving skin wrinkle or enhancing skin elasticity comprising Cynanchum wilfordii and composition prepared therefrom | |
CN102293733B (en) | Overall whitening and speckle removal skin care product | |
CN103340817B (en) | Radix puerariae whitening facial mask | |
KR101685581B1 (en) | Compositions for improving skin wrinkle or moisture comprising Orostachys japonicus and composition prepared therefrom | |
KR20140016461A (en) | Fermented sea cucumber extract and its cosmetic usage | |
KR101066676B1 (en) | A oral composition for improving beauty of skin | |
KR101295368B1 (en) | Composition for skin wrinkle improvement comprising extracts of honeybush extract or its fermentation solution as an active ingredient | |
KR20120129600A (en) | The cosmetic composition for anti-wrinkle comprising the mixture of extract of Allium cepa, Symphytum officinale, Eclipta prostrate, and Theobroma cacao | |
KR101685579B1 (en) | Method for manufacturing skin-whitener composition containing Thuja orientalis and skin-whitener composition prepared therefrom | |
KR101419464B1 (en) | The composition comprising the extract or fraction of Pleurotus eryngii var. ferulae for prevention of anti aging as an active ingredient | |
KR101449282B1 (en) | Composition for improving skin wrinkle and skin moisturing comprising Barley fermented by Pichia jadinii and Aureobasidium pullulans bacteria | |
KR100981344B1 (en) | The cosmetic composition for preventing the skin aging | |
KR101073284B1 (en) | A composition for skin external application | |
CN113631227A (en) | Antiaging agent, antioxidant, antiinflammatory agent, whitening agent, and cosmetic | |
KR101988830B1 (en) | Composition for moisturizing, improving skin elasticity, and female breast expansion | |
KR102077708B1 (en) | Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component | |
KR102221137B1 (en) | A lycoris uydoensis extract comprising anti-wrinkle, anti-inflammatory, anti-oxidation activity, and composition comprising the same, and use thereof | |
KR20100101257A (en) | Compositions for uv protection, anti-inflammatory, antioxidation and antiaging | |
KR20160003918A (en) | Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts | |
KR20080020749A (en) | Ginseng fermented by vegetable worm, the extract thereof and the use thereof | |
KR102098695B1 (en) | Cosmetic Composition Containing Extracts of Morus Alba Root and Paeonia Suffruticosa Root | |
KR20210027182A (en) | A composition comprising extract of Lilium hansonii | |
KR20070121193A (en) | Composition for protection or anti-inflammation containing one or more among rice wine extract and rice wine lees extract | |
KR20160001950A (en) | Composition for skin whitening comprising scutellaria alpina extract | |
KR102016641B1 (en) | Composition containing extract using process of herbal medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |